Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism APOL1 inhibitors(Apolipoprotein L1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Apolipoprotein L1-mediated Kidney Disease | Phase 1 | US | 07 Apr 2022 |